Global Health Impacts Of Nanotechnology Law

Small things add up: trillions of dollars of products applying nanotechnology have been marketed to consumers promising new medicines, strong packaging to protect goods from contamination, stronger eyelash mascara and long-lasting lipstick, construction materials for housing, cheaper energy, and new drugs to fight cancer. Nanotechnology applications to consumer products represent a huge slice of daily economic life, heralding a revolutionary age for science and technology. How can the benefits of nanotechnology be realized while protecting public health? Global Health Impacts of Nanotechnology Law: A Tool for Stakeholder Engagement fills a major void in legal, scientific policy discourse about nanotechnology for people who are curious about nanoscience, bioethics, and law. The pioneering, plain-language text of Dr. Ilise L. Feitshans, international health law scholar and former international civil servant, enables readers to move comfortably across disciplines and explore how nanotechnology can reshape both commerce and public health to improve daily life worldwide.

Ever since the discovery that very small particles of some substances evince different properties than the substances do in ‘bulk’ form, there has been an interest in developing ‘nanomaterials’ for commercial and industrial purposes. Although some nanomaterials exist in nature, most are chemically engineered for application in a wide variety of processes, ultimately entering the environment in many foods, drugs, cosmetics, clothing, sports goods, pesticides, packaging products and electronics, as well as in the particularly controversial form of tiny ‘machines’. Since the long-term effects of these new, laboratory-created materials and tools on health and the environment are unknown ; and as the particles are so small they can frustrate measuring and monitoring devices ; there has been a growing call for regulation of their use. This is the first book to offer a thorough analysis of the problems posed by nanotechnology in the context of existing legal schemes and trends, focusing on initiatives and debates in the European Union but also considering developments at the global level and in the United States, Canada, Australia, Japan and China. Setting out how the current debate has arisen, how existing law deals with the issues arising around nanotechnology in areas such as patent rights and manufacturers’ liability, and how various international organizations are searching for some global consensus, the book addresses topics and issues including the following: patentability of nanomaterial products and processes; trade secrecy and nanotechnology; waste and disposal issues; occupational health and safety issues; international initiatives – OECD, FAO, WHO, UNEP and the International Conference on Chemicals Management (ICCM); intersection of nanotechnology with the most important fields of economic development; the extent to which exclusive rights have been registered over early developments in nanotechnology; the practical viability of pre-market toxicity investigation and postmarketing vigilance; contractual and tortious approaches to real or potential liability for harm; application of the precautionary principle in law and regulation; and political responses to existing legislation. Nanomaterials are already a commercial reality; the regulatory debate centres on the question of how to maximize the benefits they may offer while also limiting the risk from unforeseen hazards. This book clearly and comprehensively describes the range of issues relating to the legal framework and practicalities for commercial exploitation of nanotechnologies, and as such will prove of great value and importance to corporate counsel in many manufacturing sectors as well as to regulators and policy makers in environmental and trade law. Lorna is a partner in the London office of Bird & Bird LLP.

Nanotechnology - technology at the molecular level - is held out by many as the Holy Grail for creating a trillion dollar economy and solving problems from curing cancer to reprocessing waste into products and building superfast computers. Yet, as with GMOs, many view nanotech as a high risk genie in a bottle that once uncorked has the potential to cause unpredictable, perhaps irreversible, environmental and public health disasters. With the race to bring products to market, there is pressing need to take stock of the situation and to have a full public debate about this new technological frontier. Including contributions by renowned figures such as Roland Clift, K. Eric Drexler and Arpad Pusztai, this is the first global overview of the state of nanotech and society in Europe, the USA, Japan and Canada, examining the ethics, the environmental and public health risks, and the governance and regulation of this most promising, and potentially most dangerous, of all technologies.

Should you adopt nanotechnology? If you have already adopted it, what do you need to know? What are the risks? Nanomaterials and nanotechnologies are revolutionizing the ways we treat disease, produce energy, manufacture products, and attend to our daily wants and needs. To continue to capture the promise of these transformative products, however, we need to ask critical questions about the broader impacts of nanotechnology on society and the environment. Exploring these questions, the second edition of Nanotechnology: Health and Environmental Risks gives you the latest tools to understand the risks of nanotechnology and make better decisions about using it. Examining the state of the science, the book discusses what is known, and what still needs to be understood, about nanotechnology risk. It looks at the uses of nanotechnology for energy, industry, medicine, technology, and consumer applications and explains how to determine whether there is risk—even when there is little reliable evidence—and how to manage it. Contributors cover a wide range of topics, including: Current concerns, among them perceived risks and the challenges of evaluating emerging technology A historical perspective on product safety and chemicals policy The importance of being proactive about identifying and managing health and environmental risks during product development How the concepts of sustainability and life cycle assessment can guide nanotechnology product development Methods for evaluating nanotechnology risks, including screening approaches and research How to manage risk when working with nanoscale materials at the research stage and in occupational environments What international organizations are doing to address risk issues How risk assessment can inform environmental decision making Written in easy-to-understand language, without sacrificing complexity or scientific accuracy, this book offers a wide-angle view of nanotechnology and risk. Supplying cutting-edge approaches and insight, it explains what types of risks could exist and what you can do to address them. What’s New in This Edition Updates throughout, reflecting advances in the field, new literature, and policy developments A new chapter on nanotechnology risk communication, including insights into risk perceptions and the mental models people use to evaluate technological risks An emphasis on developing nanotechnology products that are sustainable in the long term Advances in the understanding of nanomaterials toxicity Cutting-edge research on occupational exposure to nanoparticles Changes in the international landscape of organizations working on the environmental, health, and safety aspects of nanotechnologies

This is an insightful collection by leading thinkers in both regulation and nanotechnology. It confronts new technological challenges with fresh regulatory insight. John Braithwaite, Australian National University Our growing ability to manufacture materials at the atomic scale will change our lives for the better, and tomorrow s nano-economy will outperform today s information age. Or so its proponents claim. Others maintain that a future dominated by commercial incentives risks a toxicological nightmare to rival the sorry global story of asbestos. This important volume is a timely contribution to increasing international calls to regulate nanotechnologies. By investigating the ways in which we could regulate these advances, and what we are learning from regulating existing technologies, such as biotechnologies and information technologies, the book debates the roles of government, business actors and the professions in protecting and enhancing the lives of citizens. In placing particular emphasis on the lessons of earlier technology advances, this book is unique in its broad consideration of the ethical, legal and social issues entwined within the development of the nanotechnology family. The multi-jurisdictional and interdisciplinary nature of the book will appeal to governments, academics, and civil societies across many parts of the world, while also remaining accessible to informed readers with an interest in nanotechnology and the policy and governance issues associated with technology development and regulation.

An increased understanding of the environmental and human healthimpacts of engineered nanoparticles is essential for theresponsible development of nanotechnology and appropriateevidence-based policy and guidelines for risk assessment.Presenting the latest advances in the field from a variety ofscientific disciplines, this book offers a comprehensive overviewof this challenging, inter-disciplinary research area. Topics covered include: The properties, preparation and applications ofnanomaterials Characterization and analysis of manufacturednanoparticles The fate and behaviour of nanomaterials in aquatic, terrestrialand atmospheric environments Ecotoxicology and human toxicology of manufacturednanoparticles Occupational health and exposure of nanomaterials Risk assessment and global regulatory and policy responses Understanding the behaviour and impacts of nanotechnology in theenvironment and in human health is a daunting task and manyquestions remain to be answered. Environmental and Human HealthImpacts of Nanotechnology will serve as a valuable resource foracademic researchers in nanoscience and nanotechnology,environmental science, materials science and biology, as well asfor scientists in industry, regulators and policy makers.

Nanotechnology Environmental Health and Safety tackles – in depth and in breadth – the complex and evolving issues pertaining to nanotechnology's environmental health and safety (EHS). The chapters are authored by leaders in their respective fields, providing thorough analysis of their research areas. The diverse spectrum of topics include nanotechnology EHS issues, financial implications, foreseeable risks including exposure, dosage and hazards, and the implications of occupational hygiene precautions and consumer protections. The book includes real-world case studies, wherever practical, to illustrate specific issues and scenarios encountered by stakeholders positioned on the front-lines of nanotechnology-enabled industries. These case studies will appeal to, and resonate with, laboratory scientists, business leaders, regulators, service providers, and postgraduate researchers. Reviews toxicological studies and industrial initiatives, supported by numerous case studies Covers new generation of nanoparticles and significantly expands on existing material from second edition Only edited volume to collect research on the regulatory and risk implications of a wide array of industrial, environmental and consumer nanomaterials

Examining one of the fastest growing industries in the world, Ronit Justo-Hanani compares the distinctly different approaches between both sides of the Atlantic when regulating the health, safety and environmental risks of nanotechnology and its novel properties. Looking at ongoing adjustments to existing laws, Justo-Hanani details how and why, in contrast to the United States, the European Union has adopted a far more stringent, comprehensive regulatory policy for nanotechnology safety. This illuminating book shows that despite the US' prominence in global nanotechnology markets, the strict rules of the EU have been at the forefront of market regulations across the globe. With a full and comparative account of the politics and regulatory processes of nanotechnology safety in the EU and US, it ultimately argues that the EU's adaptive and proactive, capacity-building strategy, is the key to strengthening its role as a global regulatory leader. This timely book will be useful to students and scholars of regulation and governance; science, technology, and innovation policy; environmental and health policy; and international law and politics. Its practical applications will also be of interest to policymakers concerned with the advancements of nanotechnology.